Pancreatic Cancer Research Today is a free monthly online journal that collates and summarizes the latest research about Pancreatic Cancer, including details on symptoms, causes, treatment, information.

Volume 2 (2005), Issue 3 (March)

1. Increased expression of Cyr61 (CCN1) identified in peritoneal metastases from human pancreatic cancer.
   J Am Coll Surg, 200(3): 371-7. [Abstract] [Full-text]
2. Impact of taurolidin and octreotide on liver metastasis and lipid peroxidation after laparoscopy in chemical induced ductal pancreatic cancer.
   Invest New Drugs, 23(2): 157-64. [Abstract] [Full-text]
3. Microarray analyses reveal strong influence of DNA copy number alterations on the transcriptional patterns in pancreatic cancer: implications for the interpretation of genomic amplifications.
   Oncogene, 24(10): 1794-801. [Abstract] [Full-text]
4. Laparoscopic surgery in patients with sporadic and multiple insulinomas associated with multiple endocrine neoplasia type 1.
   J Gastrointest Surg, 9(3): 381-8. [Abstract] [Full-text]
5. Genetics of hereditary pancreatic carcinoma.
   Clin Lab Med, 25(1): 117-33. [Abstract] [Full-text]
6. Molecular diagnosis of solid and cystic lesions of the pancreas.
   Clin Lab Med, 25(1): 101-16. [Abstract] [Full-text]
7. Effect of preoperative biliary stenting on immediate outcome after pancreaticoduodenectomy.
   Br J Surg, 92(3): 356-61. [Abstract] [Full-text]
8. Radioisotope bone scans in the preoperative staging of hepatopancreatobiliary cancer.
   Br J Surg, 92(2): 203-7. [Abstract] [Full-text]
9. Changes to levels of serum neuron-specific enolase in a patient with small cell carcinoma of the pancreas.
   J Hepatobiliary Pancreat Surg, 12(1): 93-8. [Abstract] [Full-text]
10. A minute nonfunctioning islet cell tumor demonstrating malignant features.
    J Hepatobiliary Pancreat Surg, 12(1): 84-7. [Abstract] [Full-text]
11. Single-branch resection of the pancreas.
    J Hepatobiliary Pancreat Surg, 12(1): 71-5. [Abstract] [Full-text]
12. Safety and efficacy of laparoscopic distal pancreatectomy for the treatment of pancreatic disease.
    J Hepatobiliary Pancreat Surg, 12(1): 65-70. [Abstract] [Full-text]
13. The significance of intraoperative Doppler ultrasonography in evaluating hepatic arterial flow when assessing the indications for the Appleby procedure for pancreatic body cancer.
    J Hepatobiliary Pancreat Surg, 12(1): 55-60. [Abstract] [Full-text]
14. Thalidomide in the treatment of cancer cachexia: a randomised placebo controlled trial.
    Gut, 54(4): 540-5. [Abstract] [Full-text]
15. Gene expression profiles in pancreatic intraepithelial neoplasia reflect the effects of Hedgehog signaling on pancreatic ductal epithelial cells.
    Cancer Res, 65(5): 1619-26. [Abstract] [Full-text]
16. Interleukin-4 enhances proliferation of human pancreatic cancer cells: evidence for autocrine and paracrine actions.
    Br J Cancer, 92(5): 921-8. [Abstract] [Full-text]
17. Specific fatty acid intake and the risk of pancreatic cancer in Canada.
    Br J Cancer, 92(5): 971-7. [Abstract] [Full-text]
18. Mutations N34S and P55S of the SPINK1 gene in patients with chronic pancreatitis or pancreatic cancer and in healthy subjects: a report from Finland.
    Scand J Gastroenterol, 40(2): 225-30. [Abstract] [Full-text]
19. Pathological study of naturally occurring adenocarcinomas demonstrating differentiation in ducks.
    Avian Pathol, 33(6): 581-5. [Abstract] [Full-text]
20. Angiography and arterial stimulation venous sampling in the localization of pancreatic neuroendocrine tumours.
    Best Pract Res Clin Endocrinol Metab, 19(2): 229-39. [Abstract] [Full-text]
21. Nuclear medicine in the detection and management of pancreatic islet-cell tumours.
    Best Pract Res Clin Endocrinol Metab, 19(2): 213-27. [Abstract] [Full-text]
22. Imaging and localization of islet-cell tumours of the pancreas on CT and MRI.
    Best Pract Res Clin Endocrinol Metab, 19(2): 195-211. [Abstract] [Full-text]
23. Endoscopic ultrasound in the localisation of pancreatic islet cell tumours.
    Best Pract Res Clin Endocrinol Metab, 19(2): 177-93. [Abstract] [Full-text]
24. Cytological diagnosis of endocrine tumors of the pancreas by endoscopic ultrasound-guided fine-needle aspiration biopsy.
    Diagn Cytopathol, 32(4): 204-10. [Abstract] [Full-text]
25. Metastatic gastric tumor secondary to pancreatic adenocarcinoma.
    J Gastroenterol, 40(2): 209-12. [Abstract] [Full-text]
26. Antitumorigenic effect of proteasome inhibitors on insulinoma cells.
    Endocrinology, 146(4): 1718-26. [Abstract] [Full-text]
27. Expression of the caudal-type homeodomain transcription factors CDX 1/2 and outcome in carcinomas of the ampulla of Vater.
    J Clin Oncol, 23(9): 1811-8. [Abstract] [Full-text]
28. Smokeless tobacco use and risk of cancer of the pancreas and other organs.
    Int J Cancer, 114(6): 992-5. [Abstract] [Full-text]
29. Anti-tumor efficacy of the nucleoside analog 1-(2-deoxy-2-fluoro-4-thio-beta-D-arabinofuranosyl) cytosine (4'-thio-FAC) in human pancreatic and ovarian tumor xenograft models.
    Int J Cancer, 114(6): 1002-9. [Abstract] [Full-text]
30. Predominant Bcl-XL knockdown disables antiapoptotic mechanisms: tumor necrosis factor-related apoptosis-inducing ligand-based triple chemotherapy overcomes chemoresistance in pancreatic cancer cells in vitro.
    Cancer Res, 65(6): 2344-52. [Abstract] [Full-text]
31. Glycogen synthase kinase-3beta participates in nuclear factor kappaB-mediated gene transcription and cell survival in pancreatic cancer cells.
    Cancer Res, 65(6): 2076-81. [Abstract] [Full-text]
32. Guillain-Barré syndrome in a patient with pancreatic cancer after an epidural-general anesthetic.
    Anesth Analg, 100(4): 1197-9. [Abstract] [Full-text]
33. Glucagon production of the rat insulinoma cell line INS-1-A quantitative comparison with primary rat pancreatic islets.
    Biochem Biophys Res Commun, 330(1): 327-32. [Abstract] [Full-text]
34. Cystic neoplasms of the pancreas with mucin-production.
    Eur J Surg Oncol, 31(3): 282-7. [Abstract] [Full-text]
35. Antiangiogenic treatment with the three thrombospondin-1 type 1 repeats recombinant protein in an orthotopic human pancreatic cancer model.
    Clin Cancer Res, 11(6): 2337-44. [Abstract] [Full-text]
36. Quantitative assessment of telomerase activity and human telomerase reverse transcriptase messenger RNA levels in pancreatic juice samples for the diagnosis of pancreatic cancer.
    Clin Cancer Res, 11(6): 2285-92. [Abstract] [Full-text]
37. Basaloid carcinoma of the pancreas.
    Virchows Arch, 446(3): 322-4. [Abstract] [Full-text]
38. Mucinous cystic carcinoma of the pancreas: a unique cell line and xenograft model of a preinvasive lesion.
    Virchows Arch, 446(3): 239-45. [Abstract] [Full-text]
39. Phase II trial of oral rubitecan in previously treated pancreatic cancer patients.
    Oncologist, 10(3): 183-90. [Abstract] [Full-text]
40. Increased preoperative platelet count is associated with decreased survival after resection for adenocarcinoma of the pancreas.
    Am J Surg, 189(3): 278-82. [Abstract] [Full-text]
41. Immunobiotherapy directed against mutated and aberrantly expressed gene products in pancreas cancer.
    J Cell Biochem, 94(6): 1069-77. [Abstract] [Full-text]
42. Transgenic expression of CCK2 receptors sensitizes murine pancreatic acinar cells to carcinogen-induced preneoplastic lesions formation.
    Int J Cancer, 115(1): 46-54. [Abstract] [Full-text]
43. Proteomic profiling of pancreatic cancer for biomarker discovery.
    Mol Cell Proteomics, 4(4): 523-33. [Abstract] [Full-text]
44. Quality of life after curative or palliative surgical treatment of pancreatic and periampullary carcinoma.
    Br J Surg, 92(4): 471-7. [Abstract] [Full-text]
45. New infusion device for trans-tissue, sustained local delivery of anticancer agent to surgically resected tissue: potential use for suppression of local recurrence of pancreatic cancer.
    J Biomed Mater Res B Appl Biomater, 73(1): 203-7. [Abstract] [Full-text]
46. Resection of the celiac axis for invasive pancreatic cancer.
    J Gastrointest Surg, 9(4): 503-7. [Abstract] [Full-text]
47. BRCA1 and pancreatic cancer: pedigree findings and their causal relationships.
    Cancer Genet Cytogenet, 158(2): 119-25. [Abstract] [Full-text]
48. Impact of menopausal status on the behavior of pancreatic cystic neoplasms in women.
    Curr Surg, 62(2): 258-61. [Abstract] [Full-text]
49. Proteomics-based identification of DEAD-box protein 48 as a novel autoantigen, a prospective serum marker for pancreatic cancer.
    Biochem Biophys Res Commun, 330(2): 526-32. [Abstract] [Full-text]
50. Relationship between alphaGal epitope expression and decrease of tumorigenicity in pancreatic adenocarcinoma model.
    Mol Carcinog, 42(4): 202-12. [Abstract] [Full-text]
51. Localization of the human hedgehog-interacting protein (Hip) in the normal and diseased pancreas.
    Mol Carcinog, 42(4): 183-92. [Abstract] [Full-text]
52. Intraductal papillary-mucinous tumors arising in Santorini's duct: clinicopathologic features and the treatment of choice.
    World J Surg, 29(2): 208-11. [Abstract] [Full-text]
53. Nutrition intervention improves outcomes in patients with cancer cachexia receiving chemotherapy--a pilot study.
    Support Care Cancer, 13(4): 270-4. [Abstract] [Full-text]
54. Reproductive and menstrual risk factors for pancreatic cancer: a population-based study of San Francisco Bay Area women.
    Am J Epidemiol, 161(8): 741-7. [Abstract] [Full-text]
55. Serial in vivo loss and in vitro gain of Fas expression and function in human cancerous pancreatic duct cells.
    Int J Cancer, 115(2): 214-23. [Abstract] [Full-text]

© 2004-2008 Pancreatic Cancer Research Today. All Rights Reserved.